Candesant Biomedical
Jacob Waugh has extensive experience in the pharmaceutical and biomedical industry. Jacob is currently serving as the President and CEO of Ziropa Inc since February 2020. Prior to this, Jacob was the Founder and Chief Scientific Officer at Candesant Biomedical starting from December 2016. Jacob also founded Illustris Pharmaceuticals, Inc. in January 2017, where they held multiple roles including founder, CSO, and Inventor until January 2020. Jacob's career began at Revance Therapeutics, Inc. in July 2004, where they served as the Founder, Chief Scientific Officer, and Medical Director until December 2016.
Jacob Waugh attended Stanford University School of Medicine from 1997 to 1999, where they pursued a fellowship in Guided Tissue Remodeling.
This person is not in any teams
This person is not in any offices
Candesant Biomedical
Candesant Biomedical develops treatment for excessive sweating and hyperhidrosis. It offers a technology that is based on the principle that alkali metals in contact with water generate energy. The insight was that when the amounts of metal and water are controlled, the result is targeted delivery of energy exactly at the site of the water. Itsdevice is designed to target and inactivate the most active sweat glands.The company was founded in 2016 and is headquartered in San Francisco, California.